Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout

Educational Sessions

Getting to Know Lp(a): Why It's Important and Emerging Drug Therapies

Tuesday, December 10, 2024
2:00 PM – 3:30 PM  
Location: MCCNO, Theater A, Level 2
CE Credits: 1.50 contact hours
Activity #: 0204-0000-24-306-L01-P
Activity Type: Knowledge-based
Target Audience: Pharmacist

Learning Objectives:

  • Describe the relationship between lipoprotein (a) (Lp(a)) and cardiovascular (CV) disease including patients who should be screened for elevated Lp(a).
  • Identify the effects that current low-density lipoprotein-C (LDL-C) lowering therapies have on Lp(a) values.
  • Summarize clinical trial data that show the relationship between targeting Lp(a) and the potential impact on atherosclerotic cardiovascular disease (ASCVD) reduction.
  • Select effective patient education strategies to empower patients with lipid disorders to manage their ASCVD risk and adhere to pharmacotherapy.